INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Surgery
NCT ID: NCT05775341
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
120 participants
OBSERVATIONAL
2023-02-27
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question this study aims to determine if:
* Patients undergoing surgery develop transient intestinal dysbiosis
* Such transient dysbiosis is associated with translocation to the systemic circulation and surgical site infection
Patients undergoing elective abdominal surgery will be included prospectively. Informed consent will be obtained. From patients the following information and samples will be collected:
* Perioperative: Baseline health data, nutrition data, measurement body composition, glucose monitoring
* Intraoperatively:
* Mucosal swabs
* Blood from central venous catheter and portal vein
* Mesenteric lymph node
* Intestinal specimen
* Bile
* Subcutaneous biopsy
* Postoperatively:
* If a surgical site infection occurs samples from infected site
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bacteria and Intestinal Translocation in Surgery (Bandit)
NCT03554148
Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections
NCT06300892
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NCT06782880
Study of the Incidence of Surgical Site Infections Developed by Patients Hospitalized in the Wards of a Large Teaching Hospital in Rome, Italy
NCT05788575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
This is purely an observational study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery
* Informed consent
* Age \> 18 years
Exclusion Criteria
* Other surgery 30 days prior to surgery
* BMI \<18 or \>50kg/m2
* Planed simultaneous second procedure with involvement of the intestinal tract
* Cholestasis with cholangitis, hepatic disease (defined as cirrhosis Child B or C) or renal disease (acute or chronic renal failure defined as eGFR≤ 30ml/min)
* Severe active enteritis or colitis, malabsorption, enteric infections
* Pancreatitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guido Beldi
Role: PRINCIPAL_INVESTIGATOR
Department of Visceral Surgery and Medicine, Bern University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beldi Guido
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-01054
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.